🇺🇸 FDA
Patent

US 11541045

Methods of treating cancer with farnesyltransferase inhibitors

granted A61KA61K31/4709A61K45/06

Quick answer

US patent 11541045 (Methods of treating cancer with farnesyltransferase inhibitors) held by Kura Oncology, Inc. expires Mon Dec 29 2042 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Kura Oncology, Inc.
Grant date
Tue Jan 03 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Dec 29 2042 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
39
CPC classes
A61K, A61K31/4709, A61K45/06